期刊文献+

FFP时辰化疗+LMS治疗中晚期大肠癌41例临床分析 被引量:3

Chronomodulated Chemotherapy of Oxaliplatin Combined 5-FU and CF Plus Levamisole on Colorectal Cancer of 41 Cases
下载PDF
导出
摘要 目的降低大肠癌患者术后复发率,提高中晚期大肠癌患者的生存率。方法将71例中晚期大肠癌患者随机分成2组。治疗组41例,采用FFP(5-氟尿嘧啶、亚叶酸钙、奥沙利铂)时辰化疗+左旋咪唑(LMS)治疗:①第1天15:00-17:00给予奥沙利铂(L-OHP)150mg/m2静脉滴注;②采用微电脑控制的全自动注药泵注入5-氟尿嘧啶(5-FU)4~5g,以正弦速率在第1天22:00至第2天上午10:00注入,上午4:00达到最高峰,持续5d;③亚叶酸钙(CF)200mg/d,每天在5-FU之前注入,连用5d,3~4周为1周期;④左旋咪唑(LMS)50mg口服,3次/d。对照组30例,给予L-OHP150mg/m2、CF200mg/m2、5-FU500mg/m2分别静脉滴注。观察2组疗效及不良反应。结果治疗组和对照组1、2、3年生存率分别为96.23%、71.10%、60.83%和80.86%、67.38%、32.44%;1、2、3年肿瘤进展(TTP)率分别为58.26%、28.16%、28.16%和74.45%、58.22%、50.76%,2组比较差异均有统计学意义(均P<0.05)。2组不良反应发生率比较差异无统计学意义(P>0.05)。结论FFP时辰化疗+LMS治疗中晚期大肠癌可以起到增效、减毒作用,效果较为满意,是治疗中晚期大肠癌的有效方法。 Objective To explore the therapeutic efficacy of chronomodulated chemotherapy of oxaliplatin combined 5-FU and CF (FFP) plus levamisole (LMS) on colorectal cancer. Methods 71 patients with advanced colorectal cancer were randomly divided into two groups. Experiment group(n=41) was employed the chronomodulated chemotherapy of FFP plus LMS: (1)Oxaliplatin (L-OHP) was injected at 15:00-17:00 in the first day;(2)5-FU was infused in sine velocity with an auto-infusion pump that controlled by a microcomputer from 22:00 of the first day to 10:00 of the next day with a concentration peak at 4.00,lasted 5 days;(3) Leucovorin(CF)was infused before administration of 5-FU everyday, lasted 5 days, 3-4 weeks repeatedly;(4)All patients received LMS 50 mg p.o.t.i.d, on days 1-3,every 14 days for 12 months. Control group (n=30) was treated by injecting L-OHP 150 mg/m^2 ,CF 200 mg/m^2 and 5-FU 500 mg/m^2 respectively. The therapeutic efficacy and adverse drug reaction were investigated. Results The 1,2,3 year survival rate of experiment group and control group was 96.23% ,71.10% ,60.83% and 80.86%, 67.38%,32.44%,respectively (P〈0. 05). The 1,2,3 year TTP rate of experiment group was significantly lower than those of control group(58.26% ,28.16% ,28.16% vs 74.45% ,58.22%, 50.76% ;P〈0.05). The percentage of adverse drug reactions had no significant difference between the two groups(P〉0.05). Conclusion The combination of chronomodulated chemotherapy of FFP with LMS may be more effective and may cause the lower adverse drug reactions on advanced colorectal carcinoma.
出处 《江西医学院学报》 CAS 2009年第4期79-81,共3页 Acta Academiae Medicinae Jiangxi
关键词 大肠癌 时辰化疗 奥沙利铂 左旋咪唑 colorectal carcinoma chronomodulated chemotherapy oxaliplatin levamisole
  • 相关文献

参考文献5

  • 1Bourquin C,Schreiber S,Beck S,et al.Immunotherapy with Dendritic Cells and CpG Oligonucleotides Can be Combined with Chemotherapy without Loss of Efficacy in a Mouse Model of Colon Cancer[J].Int J Cancer,2006,118(11):2790-2795.
  • 2Matsuoka T,Morikage N,Kobayashi T,et al.A Case of Colon Cancer with Multiple Liver,Lung and Bone Metastases Successfully Treated with Combined Weekly High-dose 5-FU(WHF) Chemotherapy with UFT and CPT-11[J].Gan To Kagaku Ryoho,2005,32(10):1481-1484.
  • 3Harris B E,Song R,He Y J,et al.Circadian Rhythm of Rat Liver Dihydropyrimidine Dehydrogenase.Possible Relevance to Fluoropyrimidine Chemotherapy[J].Biochem Pharamcol,1988,37(24):4759-4762.
  • 4李智,庄竞,韩广森,姬社青.左旋咪唑对大肠癌患者围手术期的免疫状态的影响[J].肿瘤防治杂志,2003,10(10):1098-1099. 被引量:7
  • 5苏庆光,王希照.卡莫氟与左旋咪唑治疗晚期大肠癌的临床观察[J].辽宁药物与临床,2001,4(4):151-152. 被引量:2

二级参考文献4

  • 1[1]Hobday TJ,Erlichman C. Adjuvant therapy of colon cancer:a review[J].Clin Colorectal Cancer,2002,1(4):230-236.
  • 2[2]Holcombe RF,Milovanovic T,Stewart RM,et al. Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints[J].Cancer Detect Prev,2001,25(2):183-191.
  • 3[3]Taal BG,Van Tinteren H,Zoetmulder FA,et al. Adjuvant 5FU plus levamisole in colonic or rectal cancer:improved survival in stage Ⅱ and Ⅲ[J].Br J Cancer,2001,85(10):1437-1443.
  • 4[4]Moertel CG,Fleming TR,Macdonald JS,et al. Fluorouracilplus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma:a final report[J].Ann Int Med,1995,122(5):321-326.

共引文献6

同被引文献24

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部